OMB APPROVAL

      OMB Number: 3235-0145

      Expires: October 31, 2002

      Estimated average burden

      hours per response. . . 14.9

















UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549





SCHEDULE 13G

Under the Securities Exchange Act of 1934

(Amendment No. __01____)*













(Name of Issuer)	MEDICIS PHARMACEUTICAL CORP.











(Title of Class of Securities)		Common stock











(CUSIP Number)				584690309











(Date of Event Which Requires Filing of this Statement)	November 30, 2007





Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:

      [   ]Rule 13d-1(b)

      [ X ]Rule 13d-1(c)

      [   ]Rule 13d-1(d)



*The remainder of this cover page shall be filled out for a reporting person's

initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the

disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of

1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the

Notes).



Potential persons who are to respond to the collection of

information contained in this form are not required to respond unless the

form displays a currently valid OMB control number.





      CUSIP No. ..584690309....







          1.Names of Reporting Persons.

      I.R.S. Identification Nos. of above persons (entities only).

		BNP Paribas Arbitrage SA
		23-3022591

.................................................................................








      2. Check the Appropriate Box if a Member of a Group (See Instructions)





      (a).......................................................................


      (b).......................................................................






      3.SEC Use Only

      ..........................................................................






      4.Citizenship or Place of Organization

	France

      .........................................................................

      Number of

      Shares

      Beneficially

      Owned by

      Each Reporting

      Person With

      5.Sole Voting Power 		2,272,666

      ..........................................................................




      6.Shared Voting Power

      ..........................................................................




      7.Sole Dispositive 		2,272,666

      Power.....................................................................






      8.Shared Dispositive Power

      ..........................................................................






      9.Aggregate Amount Beneficially Owned by Each Reporting 	2,272,666

      Person................................................................









      10.Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See

      Instructions).................................









      11.Percent of Class Represented by Amount in Row (9) 	4.0%

      ..........................................................................








      12.Type of Reporting Person (See Instructions)	OO







      ..........................................................................


      ..........................................................................


      ..........................................................................


      ..........................................................................


      ..........................................................................


      ..........................................................................




















INSTRUCTIONS FOR SCHEDULE 13G

Instructions for Cover Page

      (l)Names and I.R.S. Identification Numbers of Reporting Persons-Furnish

      the full legal name of each person for whom the report is filed-i.e., each
      person required to sign the schedule itself-including each member of a

      group. Do not include the name of a person required to be identified in

      the report but who is not a reporting person. Reporting persons that are

      entities are also requested to furnish their I.R.S. identification

      numbers, although disclosure of such numbers is voluntary, not mandatory

      (see "SPECIAL INSTRUCTIONS FOR COMPLYING WITH SCHEDULE 13G" below).

      (2)If any of the shares beneficially owned by a reporting person are held
      as a member of a group and that membership is expressly affirmed, please

      check row 2(a). If the reporting person disclaims membership in a group or
      describes a relationship with other persons but does not affirm the

      existence of a group, please check row 2(b) [unless it is a joint filing

      pursuant to Rule 13d1(k)(1) in which case it may not be necessary to check
      row 2(b)].

      (3)The third row is for SEC internal use; please leave blank.

      (4)Citizenship or Place of Organization-Furnish citizenship if the named

      reporting person is a natural person. Otherwise, furnish place of

      organization.

      (5)-(9), (11)Aggregate Amount Beneficially Owned By Each Reporting Person,
      Etc.-Rows (5) through (9) inclusive, and (11) are to be completed in

      accordance with the provisions of Item 4 of Schedule 13G. All percentages
      are to be rounded off to the nearest tenth (one place after decimal

      point).

      (10)Check if the aggregate amount reported as beneficially owned in row

      (9)does not include shares as to which beneficial ownership is disclaimed
      pursuant to Rule 13d-4 (17 CFR 240.13d-4] under the Securities Exchange

      Act of 1934.

      (12)Type of Reporting Person-Please classify each "reporting person"

      according to the following breakdown (see Item 3 of Schedule 13G) and

      place the appropriate symbol on the form:

            CategorySymbol

            Broker Dealer BD

            Bank BK

            Insurance Company IC

            Investment Company IV

            Investment Adviser IA

            Employee Benefit Plan, Pension Fund, or Endowment Fund EP

            Parent Holding Company/Control Person HC

            Savings Association SA

            Church Plan CP

            Corporation CO

            Partnership PN

            Individual IN

            Other OO









      Notes:Attach as many copies of the second part of the cover page as are

      needed, one reporting person per page.

      Filing persons may, in order to avoid unnecessary duplication, answer

      items on the schedules (Schedule 13D, 13G or 14D1) by appropriate cross

      references to an item or items on the cover page(s). This approach may

      only be used where the cover page item or items provide all the disclosure
      required by the schedule item. Moreover, such a use of a cover page item

      will result in the item becoming a part of the schedule and accordingly

      being considered as "filed" for purposes of Section 18 of the Securities

      Exchange Act or otherwise subject to the liabilities of that section of

      the Act.

      Reporting persons may comply with their cover page filing requirements by
      filing either completed copies of the blank forms available from the

      Commission, printed or typed facsimiles, or computer printed facsimiles,

      provided the documents filed have identical formats to the forms

      prescribed in the Commission's regulations and meet existing Securities

      Exchange Act rules as to such matters as clarity and size (Securities

      Exchange Act Rule 12b-12).







SPECIAL INSTRUCTIONS FOR COMPLYING WITH SCHEDULE 13G

Under Sections 13(d), 13(g), and 23 of the Securities Exchange Act of 1934 and

the rules and regulations thereunder, the Commission is authorized to solicit

the information required to be supplied by this schedule by certain security

holders of certain issuers.

Disclosure of the information specified in this schedule is mandatory, except

for I.R.S. identification numbers, disclosure of which is voluntary. The

information will be used for the primary purpose of determining and disclosing

the holdings of certain beneficial owners of certain equity securities. This

statement will be made a matter of public record. Therefore, any information

given will be available for inspection by any member of the public.

Because of the public nature of the information, the Commission can use it for a
variety of purposes, including referral to other governmental authorities or

securities self-regulatory organizations for investigatory purposes or in

connection with litigation involving the Federal securities laws or other civil,
criminal or regulatory statutes or provisions. I.R.S. identification numbers, if
furnished, will assist the Commission in identifying security holders and,

therefore, in promptly processing statements of beneficial ownership of

securities.

Failure to disclose the information requested by this schedule, except for

I.R.S. identification numbers, may result in civil or criminal action against

the persons involved for violation of the Federal securities laws and rules

promulgated thereunder.







GENERAL INSTRUCTIONS

      A.Statements filed pursuant to Rule 13d-1(b) containing the information

      required by this schedule shall be filed not later than February 14

      following the calendar year covered by the statement or within the time

      specified in Rules 13d-1(b)(2) and 13d2(c). Statements filed pursuant to

      Rule 13d-1(c) shall be filed within the time specified in Rules 13d-1(c),
      13d-2(b) and 13d-2(d). Statements filed pursuant to Rule 13d-1(d) shall be
      filed not later than February 14 following the calendar year covered by

      the statement pursuant to Rules 13d-1(d) and 13d-2(b).

      B.Information contained in a form which is required to be filed by rules

      under section 13(f) (15 U.S.C. 78m(f)) for the same calendar year as that
      covered by a statement on this schedule may be incorporated by reference

      in response to any of the items of this schedule. If such information is

      incorporated by reference in this schedule, copies of the relevant pages

      of such form shall be filed as an exhibit to this schedule.

      C.The item numbers and captions of the items shall be included but the

      text of the items is to be omitted. The answers to the items shall be so

      prepared as to indicate clearly the coverage of the items without

      referring to the text of the items. Answer every item. If an item is

      inapplicable or the answer is in the negative, so state.





      Item 1.



      (a)Name of Issuer		Medicis Pharmaceutical Corp.



      (b)Address of Issuer's Principal Executive Offices

	8125 North Hayden Road
	Scottsdale, AZ 85258


      Item 2.



      (a)Name of Person Filing		BNP Paribas Arbitrage SA





      (b)Address of Principal Business Office or, if none, Residence



	787 Seventh Ave.
	New York, NY 10019



      (c)Citizenship	France



      (d)Title of Class of Securities		Common Stock



      (e)CUSIP Number				584690309



      Item 3.If this statement is filed pursuant to 240.13d-1(b) or

      240.13d-2(b) or (c), check whether the person filing is a:



      (a)[   ]Broker or dealer registered under section 15 of the Act (15 U.S.C.
      78o).



      (b)[   ]Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).



      (c)[   ]Insurance company as defined in section 3(a)(19) of the Act (15

      U.S.C. 78c).



      (d)[   ]Investment company registered under section 8 of the Investment

      Company Act of 1940 (15 U.S.C 80a-8).



      (e)[ ] An investment adviser in accordance with 240.13d-1(b)(1)(ii)(E);



      (f)[   ]An employee benefit plan or endowment fund in accordance with

      240.13d-1(b)(1)(ii)(F);



      (g)[   ]A parent holding company or control person in accordance with

      240.13d-1(b)(1)(ii)(G);



      (h)[   ]A savings associations as defined in Section 3(b) of the Federal

      Deposit Insurance Act (12 U.S.C. 1813);



      (i)[   ]A church plan that is excluded from the definition of an

      investment company under section 3(c)(14) of the Investment Company Act of
      1940 (15 U.S.C. 80a-3);



      (j)[   ]Group, in accordance with 240.13d-1(b)(1)(ii)(J).





      Item 4.Ownership.

      Provide the following information regarding the aggregate number and

      percentage of the class of securities of the issuer identified in Item 1.


      (a)Amount beneficially owned: 2,272,666

      (b)Percent of class: 4.0%.



      (c)Number of shares as to which the person has:





      (i)Sole power to vote or to direct the vote 2,272,666





      (ii)Shared power to vote or to direct the vote __________________.





      (iii)Sole power to dispose or to direct the disposition of

      2,272,666





      (iv)Shared power to dispose or to direct the disposition of

      _______________.

      Instruction. For computations regarding securities which represent a right
      to acquire an underlying security see 240.13d3(d)(1).





      Item 5.Ownership of Five Percent or Less of a Class

      If this statement is being filed to report the fact that as of the date

      hereof the reporting person has ceased to be the beneficial owner of more
      than five percent of the class of securities, check the following [ X ].

      Instruction: Dissolution of a group requires a response to this item.





      Item 6.Ownership of More than Five Percent on Behalf of Another Person.

      If any other person is known to have the right to receive or the power to
      direct the receipt of dividends from, or the proceeds from the sale of,

      such securities, a statement to that effect should be included in response
      to this item and, if such interest relates to more than five percent of

      the class, such person should be identified. A listing of the shareholders
      of an investment company registered under the Investment Company Act of

      1940 or the beneficiaries of employee benefit plan, pension fund or

      endowment fund is not required.





      Item 7.Identification and Classification of the Subsidiary Which Acquired
      the Security Being Reported on By the Parent Holding Company

      If a parent holding company has filed this schedule, pursuant to Rule

      13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating
      the identity and the Item 3 classification of the relevant subsidiary. If
      a parent holding company has filed this schedule pursuant to Rule 13d-1(c)
      or Rule 13d-1(d), attach an exhibit stating the identification of the

      relevant subsidiary.





      Item 8.Identification and Classification of Members of the Group

      If a group has filed this schedule pursuant to 240.13d-1(b)(1)(ii)(J), so
      indicate under Item 3(j) and attach an exhibit stating the identity and

      Item 3 classification of each member of the group. If a group has filed

      this schedule pursuant to 240.13d-1(c) or 240.13d-1(d), attach an

      exhibit stating the identity of each member of the group.





      Item 9.Notice of Dissolution of Group

      Notice of dissolution of a group may be furnished as an exhibit stating

      the date of the dissolution and that all further filings with respect to

      transactions in the security reported on will be filed, if required, by

      members of the group, in their individual capacity. See Item 5.





      Item 10.Certification



      (a)The following certification shall be included if the statement is filed
      pursuant to 240.13d-1(b):

        By signing below I certify that, to the best of my knowledge and belief,
        the securities referred to above were acquired and are held in the

        ordinary course of business and were not acquired and are not held for

        the purpose of or with the effect of changing or influencing the control
        of the issuer of the securities and were not acquired and are not held

        in connection with or as a participant in any transaction having that

        purpose or effect.



      (b)The following certification shall be included if the statement is filed
      pursuant to 240.13d-1(c):

        By signing below I certify that, to the best of my knowledge and belief,
        the securities referred to above were not acquired and are not held for
        the purpose of or with the effect of changing or influencing the control
        of the issuer of the securities and were not acquired and are not held

        in connection with or as a participant in any transaction having that

        purpose or effect.




	By signing below I certify that, to the best of my knowledge and belief,
        the securities referred to above were not acquired and are not held for
        the purpose of or with the effect of changing or influencing the control
        of the issuer of the securities and were not acquired and are not held

        in connection with or as a participant in any transaction having that

        purpose or effect.







Person Signing this Report on Behalf of Reporting Manager:





Name:     Brenda Hinton

Title:    Director, Compliance

Phone:    (917) 472-4792

Signature ,Place, and Date of Signing:

Brenda Hinton

New York, NY

December 13, 2007





The original statement shall be signed by each person on whose behalf the

statement is filed or his authorized representative. If the statement is signed
on behalf of a person by his authorized representative other than an executive

officer or general partner of the filing person, evidence of the

representative's authority to sign on behalf of such person shall be filed with
the statement, provided, however, that a power of attorney for this purpose

which is already on file with the Commission may be incorporated by reference.

The name and any title of each person who signs the statement shall be typed or
printed beneath his signature.

NOTE: Schedules filed in paper format shall include a signed original and five

copies of the schedule, including all exhibits. See 240.13d-7 for other parties
for whom copies are to be sent.

      Attention:Intentional misstatements or omissions of fact constitute

      Federal criminal violations

      (See 18 U.S.C. 1001)